URL copied to clipboard

Trending News

Northern Arc Capital Soars 33% Above IPO Price on BSE Debut, Surging to ₹351!

Northern Arc Capital debuted on the BSE at ₹351, a 33.46% premium over the ₹263 IPO price, reflecting strong investor demand and positive market sentiment towards the company.
Northern Arc Capital Soars 33% Above IPO Price on BSE Debut, Surging to ₹351!

Northern Arc Capital made its stock market debut, listing at ₹351 per share on the BSE, reflecting a 33.46% premium, ₹88 higher than the IPO issue price of ₹263 per share, indicating strong investor demand and positive market sentiment toward the company.

Alice Blue Image

Northern Arc Capital Limited IPO final day subscription numbers showed impressive results. Qualified Institutional Buyers (QIBs) subscribed 240.79 times, Non-Institutional Investors 142.41 times, Retail Individual Investors (RIIs) 31.08 times, and Employees 7.33 times, leading to an overall subscription of 110.91 times.

Northern Arc Capital, established to serve underserved Indian households and businesses, has evolved into a leading diversified NBFC with significant AUM as of March 2024. The company’s broad-based approach spans MSME, MFI, and consumer finance sectors, where it has been active for over 14, 15, and nine years respectively, catering to varied borrower categories across India.

The main objective of Northern Arc Capital Limited is to meet future capital requirements towards onward lending.

Loading
Read More News

Onyx Biotec IPO पहले दिन 2.80 गुना सब्सक्रिप्शन के साथ शानदार शुरुआत – अधिक जानकारी के लिए पढ़ें!

Onyx Biotec IPO को पहले दिन 2.80 गुना सब्सक्रिप्शन मिला, जो निवेशकों के मजबूत विश्वास और सार्वजनिक पेशकश के शुरुआती